- Global Pharma News & Resources

B-Cell Non-Hodgkin Lymphoma Pipeline Insights, 2019 Report -

The "B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2019" drug pipelines has been added to's offering.

"B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across B-Cell Non-Hodgkin Lymphoma development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active B-Cell Non-Hodgkin Lymphoma pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. B-Cell Non-Hodgkin Lymphoma Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for B-Cell Non-Hodgkin Lymphoma

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • Gilead Sciences
  • Pfizer
  • CTI BioPharma
  • Shanghai Henlius Biotech
  • MorphoSys AG
  • Amgen
  • Janssen Research & Development LLC
  • Mabion SA
  • Celgene
  • TG Therapeutics Inc.
  • Sinocelltech Ltd.
  • Innovent Biologics (Suzhou) Co. Ltd.
  • Mundipharma Research Limited
  • Biocad
  • ImmunoGen Inc
  • Karyopharm Therapeutics Inc

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 28-Jan-2019